{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:42:51Z","timestamp":1786725771155,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Antipsychotic drugs have the potential to cause QT-interval prolongation (QTIP), which may lead to Torsades de Pointes and sudden cardiac death. Thus, it is important to know about the incidence and risk factors for QTIP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>The primary objective of the study was to find out the incidence of QTIP due to the use of antipsychotic drugs in patients with schizophrenia and acute psychosis after two weeks of drug use. The secondary objective was to find the risk factors for QTIP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>The study included 160 consenting patients, aged \u226518 years, either sex, diagnosed with schizophrenia or acute psychosis, who had not taken oral\/water-based injectable antipsychotics during the last 15 days or any long-acting antipsychotic injectable during the previous 6 months. Patients with other psychiatric disorders, substance use other than nicotine\/caffeine, low serum levels of potassium\/calcium\/magnesium, congenital long QT syndrome, history of cardiac conditions, or those taking drugs with high risk to cause QTIP were excluded. ECG was recorded before starting treatment and after at least 2 weeks of treatment with antipsychotic drugs. Corrected QT interval (QTc) was calculated using Fridericia\u2019s and Bazett\u2019s formulae. QTc &gt;450 ms in males and &gt;460 ms in females was considered prolonged.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The mean age of study participants was 35.88 years (SD: 13.32), and 88 (55%) were males; 138 (86.3%) suffered from schizophrenia. Seventy-one (44.4%) and 74 (46.3%) received risperidone and olanzapine, respectively. Twelve (7.5%) developed QTIP (QTc calculated using Fridericia\u2019s formula). Twenty-five (15.6%) were seen to develop QTIP (QTc calculated using Bazett\u2019s formula). Additional risk factors for QTIP could not be identified in the study sample.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>QTIP is present in a reasonable number of participants. Careful screening and assessment for risk factors that could increase the chances of QTIP must be done regularly in patients getting antipsychotic drugs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ipj.ipj_495_24","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T08:00:18Z","timestamp":1752912018000},"page":"228-235","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["QT interval prolongation from antipsychotics in schizophrenia and acute psychosis - A prospective study"],"prefix":"10.4103","volume":"34","author":[{"given":"Anirban","family":"Saha","sequence":"first","affiliation":[{"name":"Department of Psychiatry, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyajit","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Cardiology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Somani","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"R2-20260422","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/0957154X241245886","article-title":"Historical and conceptual features of acute polymorphic psychosis: A myth of European psychiatry from bouff\u00e9e d\u00e9lirante to ICD-11 acute and transient psychotic disorder","volume":"35","author":"Castagnini","year":"2024","journal-title":"Hist Psychiatry"},{"key":"R3-20260422","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1176\/appi.ajp.2019.1760501","article-title":"QTc prolongation and psychotropic medications","volume":"177","author":"Funk","year":"2020","journal-title":"Am J Psychiatry"},{"key":"R4-20260422","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.pra.0000450319.21859.6d","article-title":"QTc prolongation with antipsychotics: Is routine ECG monitoring recommended?","volume":"20","author":"Shah","year":"2014","journal-title":"J Psychiatr Pract"},{"key":"R5-20260422","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2008.12.014","article-title":"AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: Part IV: The ST segment, T and U waves, and the QT interval: A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology","volume":"53","author":"Rautaharju","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R6-20260422","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jamapsychiatry.2018.2726","article-title":"Can better cardiovascular care close the mortality gap for people with schizophrenia?","volume":"75","author":"Druss","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"R7-20260422","doi-asserted-by":"crossref","first-page":"704045","DOI":"10.3389\/fpsyt.2021.704045","article-title":"The prevalence, risk factors and clinical correlates of QTc prolongation in Chinese hospitalized patients with chronic schizophrenia","volume":"12","author":"Cao","year":"2021","journal-title":"Front Psychiatry"},{"key":"R8-20260422","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/0973-1229.104497","article-title":"Polypharmacy in psychiatry: A review","volume":"11","author":"Kukreja","year":"2013","journal-title":"Mens Sana Monogr"},{"key":"R9-20260422","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/j.2051-5545.2011.tb00036.x","article-title":"Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level","volume":"10","author":"De Hert","year":"2011","journal-title":"World Psychiatry"},{"key":"R10-20260422","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12888-020-02687-w","article-title":"Prevalence of QTc interval prolongation and its associated risk factors among psychiatric patients: A prospective observational study","volume":"20","author":"Ali","year":"2020","journal-title":"BMC Psychiatry"},{"key":"R11-20260422","doi-asserted-by":"crossref","first-page":"2045125319891386","DOI":"10.1177\/2045125319891386","article-title":"Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patients","volume":"9","author":"Ansermot","year":"2019","journal-title":"Ther Adv Psychopharmacol"},{"key":"R12-20260422","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/1039856217726212","article-title":"A review of ECG and QT interval measurement use in a public psychiatric inpatient setting","volume":"26","author":"Berling","year":"2018","journal-title":"Australas Psychiatry"},{"key":"R13-20260422","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1017\/S1092852917000402","article-title":"QTc interval in patients with schizophrenia receiving antipsychotic treatment as monotherapy or polypharmacy","volume":"23","author":"Elliott","year":"2018","journal-title":"CNS Spectr"},{"key":"R14-20260422","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1017\/S2045796015000906","article-title":"Prevalence and correlates of QTc prolongation in Italian psychiatric care: Cross-sectional multicentre study","volume":"25","author":"Nos\u00e8","year":"2016","journal-title":"Epidemiol Psychiatr Sci"},{"key":"R15-20260422","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/kjm2.12280","article-title":"QT interval prolongation noted in one percent of 2553 Asian patients with schizophrenia: Findings from the REAP-AP survey","volume":"36","author":"Park","year":"2020","journal-title":"Kaohsiung J Med Sci"},{"key":"R16-20260422","first-page":"354","article-title":"Electrocardiogram characteristics and their association with psychotropic drugs among patients with schizophrenia","volume":"46","author":"Polcwiartek","year":"2020","journal-title":"Schizophr Bull"},{"key":"R17-20260422","first-page":"21m02915","article-title":"Prevalence and risk factors for QTc prolongation in acute psychiatric hospitalization","volume":"24","author":"Salvati","year":"2022","journal-title":"Prim Care Companion CNS Disord"},{"key":"R18-20260422","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.schres.2023.09.032","article-title":"Prevalence and predictors of QTc prolongation in patients seen in a clozapine clinic in a real-world setting in Australia","volume":"268","author":"Sankaranarayanan","year":"2023","journal-title":"Schizophr Res"},{"key":"R19-20260422","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"R21-20260422","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/0970-0218.116358","article-title":"Modified Kuppuswamy\u2019s Socioeconomic Scale: Social researcher should include updated income criteria, 2012","volume":"38","author":"Bairwa","year":"2013","journal-title":"Indian J Community Med"},{"key":"R22-20260422","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol Rep"},{"key":"R23-20260422","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.schres.2007.12.470","article-title":"The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder","volume":"100","author":"Byerly","year":"2008","journal-title":"Schizophr Res"},{"key":"R24-20260422","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3126\/ajms.v15i4.61308","article-title":"A prospective study on change of QTc interval with antipsychotic medications in patients of schizophrenia and related psychotic disorder","volume":"15","author":"Mandal","year":"2024","journal-title":"Asian J Med Sci"},{"key":"R25-20260422","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/ipj.ipj_149_23","article-title":"QTc interval changes among patients on psychotropic medications: A prospective observational study","volume":"33","author":"Munivenkatappa","year":"2024","journal-title":"Ind Psychiatry J"},{"key":"R26-20260422","doi-asserted-by":"crossref","first-page":"161","DOI":"10.15420\/aer.2019.8.3.G1","article-title":"British Heart Rhythm Society clinical practice guidelines on the management of patients developing QT prolongation on antipsychotic medication","volume":"8","author":"Lambiase","year":"2019","journal-title":"Arrhythm Electrophysiol Rev"}],"container-title":["Industrial Psychiatry Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ipj.ipj_495_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:25:29Z","timestamp":1786724729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ipj.ipj_495_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ipj.ipj_495_24","relation":{},"ISSN":["0972-6748","0976-2795"],"issn-type":[{"value":"0972-6748","type":"print"},{"value":"0976-2795","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"2024-12-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}